Please Wait

Applying Filters...

Cefepime HCl
CEP/COS
Table View

Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Cefepime HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

29 API Suppliers, 9 USDMF, 1 CEP/COS, 6 JDMF, 1 EU WC, 15 KDMF, 7 NDC API, 3 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

52 FDF Dossiers, 27 FDA Orange Book, 8 Europe, 3 Canada, 10 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Pfanstiehl, 2 Kirsch Pharma, 1 Actylis, 1 Pluviaendo, 4 Roquette

EXCIPIENTS BY APPLICATIONS

5 Parenteral, 2 Fillers, Diluents & Binders, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 2 Regulatory FDF Prices

MARKET PLACE

8 APIs

8 APIs

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Fresenius Kabi Anti-Infectives	Italy	FRESENIUS KABI IPSUM S.R.L. Cassina de’ Pecchi IT	CEP 2022-460 - Rev 00	Cefepime dihydrochloride monohydrate, Sterile, process 2	2023-09-13	Valid	Chemical		2126

Contact us
to update this info

Cefepime HCl

Cefepime HCl

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

29 API Suppliers

9 USDMF

1 CEP/COS

6 JDMF

1 EU WC

15 KDMF

7 NDC API

3 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

52 FDF Dossiers

27 FDA Orange Book

8 Europe

3 Canada

10 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Pfanstiehl

2 Kirsch Pharma

1 Actylis

1 Pluviaendo

4 Roquette

EXCIPIENTS BY APPLICATIONS

5 Parenteral

2 Fillers, Diluents & Binders

1 API Stability Enhancers

1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

5 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions

2 Regulatory FDF Prices

MARKET PLACE

8 APIs

REF. STANDARDS & IMPURITIES

1 USP

1 Others

Filters

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons